# A Study to Access the Efficacy and Safety of Meloxicam in Patients With Osteoarthritis of the Knee

> **NCT02183116** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 30 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Meloxicam

## Key facts

- **NCT ID:** NCT02183116
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** 1999-02
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02183116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02183116, "A Study to Access the Efficacy and Safety of Meloxicam in Patients With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02183116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*